MedTrace Logo

Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens

NCT00927667 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2013-02-20

No results posted yet for this study

Summary

The joint status (knees, ankles) of patients suffering from severe Hemophilia A (too little blood clotting factor VIII in blood) is evaluated in a single magnetic resonance imaging session. No study medication is given.

Conditions

Interventions

PROCEDURE

No Drug

Patients have received primary FVIII prophylaxis (started \< 2 years of age)

PROCEDURE

No Drug

Patients have received secondary FVIII prophylaxis (started 2 - \< 6 years of age)

PROCEDURE

No Drug

Patients have received secondary FVIII prophylaxis (started 6 - \< 12 years of age)

PROCEDURE

No Drug

Patients have received secondary VIII prophylaxis(started 12 - 18 years of age)

PROCEDURE

No Drug

Patients have received on-demand therapy

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Germany
  • Greece
  • Italy
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00927667 on ClinicalTrials.gov